Erik Eliasson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations.
Journal: The Journal of antimicrobial chemotherapy
Published: November 23, 2025
Is current guidance for cloxacillin prophylaxis dosages in hip and knee arthroplasty adequate? Evidence from a prospective Swedish cohort.
Journal: The Journal of antimicrobial chemotherapy
Published: May 15, 2025
CYP2D6 genotype and outcome in tamoxifen treated early breast cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 18, 2025
First dose target attainment with extended infusion regimens of piperacillin and meropenem.
Journal: Critical care (London, England)
Published: February 04, 2025
PharmFreq: a comprehensive atlas of ethnogeographic allelic variation in clinically important pharmacogenes.
Journal: Nucleic acids research
Published: August 12, 2024
Development and clinical implementation of an LC-HRMS method for ivacaftor, lumacaftor, tezacaftor and elexacaftor in human plasma and breast milk.
Journal: Analytical and bioanalytical chemistry
Published: June 11, 2024
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial.
Journal: Journal of the National Cancer Institute
Published: April 17, 2024
Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records.
Journal: Breast cancer research and treatment
Published: December 08, 2022
Last Updated: 09/26/2026